Evidence map›Paper›PMID 39936737›Full record

ArticleArquivos brasileiros de cardiologia2025

Vortioxetine's Therapeutic Potential: Cardiac Responses to Chronic Unpredictable Mild Stress in a Rat Model.

Ozlem Ozmen, Serife Tasan, Gulin Ozdamar Unal

Abstract readEvaluation Study
In one paragraph

Article in Arquivos brasileiros de cardiologia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Cardiac Response to Stress: Influence of Vortioxetine.Arquivos brasileiros de cardiologia · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ozlem OzmenBurdur Mehmet Akif Ersoy University - Department of Pathology, Burdur - Turquia.ORCID 0000-0002-1835-1082
Serife TasanBurdur Mehmet Akif Ersoy University - Department of Pathology, Burdur - Turquia.
Gulin Ozdamar UnalSuleyman Demirel University - Department of Psychiatry, Isparta - Turquia.ORCID 0000-0002-6750-468X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStress arises in response to threats or challenges, affecting both physical and mental health. While its harmful effects on the heart are widely recognized, cellular-level investigations remain limited. Antidepressants, including vortioxetine (VOR), are known to impact the cardiovascular system. VOR, used to treat major depressive disorder, is considered a promising option for patients with heart disease due to its anti-inflammatory and antioxidant properties, which may reduce cardiac damage.

objectivesThis study aimed to assess the effects of chronic unpredictable mild stress (CUMS) on rat hearts and evaluate VOR's potential protective effects against stress-induced cardiac damage.

methodsTwenty-eight male Wistar Albino rats were divided into four groups. The CUMS group experienced random daily stress for 6 weeks, while the CUMS+VOR group received VOR treatment alongside stress. VOR and control groups were not exposed to stress. Heart samples were examined histopathologically and immunohistochemically.

resultsThe CUMS group showed increased hyperemia, hemorrhage, edema, vacuolar degeneration, and mononuclear cell infiltrations, with reduced troponin and IL-10 and increased caspase-3 and NF-κB expressions compared to the control group (p≤0.001). VOR treatment improved these findings, normalizing histopathological and immunohistochemical results.

conclusionsCUMS caused significant cardiac damage in rats, while VOR treatment showed protective effects by alleviating these pathological changes.

Indexed as

Antidepressive AgentsHeartHeart DiseasesPiperazinesStress, PsychologicalVortioxetineAnimalsCaspase 3Chronic DiseaseDisease Models, AnimalImmunohistochemistryInterleukin-10MaleMyocardiumNF-kappa BRandom AllocationAntidepressive AgentsCaspase 3Interleukin-10NF-kappa BPiperazinesTroponinVortioxetine

Identifiers

PMID39936737
PMCPMC11805572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.